Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp > SBM mgmt, get on with it

<< Previous

Bullboard Posts

Next >>

Comment by biorunon Jun 01, 2023 9:22pm

188 Views

Post# 35476110

RE:SBM mgmt, get on with it

The shelves are full with products that don't work well and yet still find oddly remarkable growth channels. I have tried many and the women around me say the exact same thing.

We should all be looking forward to market introduction of the TFC 1067 dyschromia treatment, and we finally get our payday with AbbVie. The question I have is how global it gets and what share of product sales can materialize.

<< Previous

Bullboard Posts

Next >>

Nickelex Resource to acquire Arlington Gold Property